Abrams C S, Wu H, Zhao W, Belmonte E, White D, Brass L F
Department of Medicine, University of Pennsylvania, Philadelphia, USA.
J Biol Chem. 1995 Jun 16;270(24):14485-92. doi: 10.1074/jbc.270.24.14485.
Pleckstrin is a 40-kDa protein present in platelets and leukocytes that contains two PH domains separated by a 150-residue intervening sequence. Pleckstrin is a major substrate for protein kinase C, but its function is unknown. The present studies examine the effects of pleckstrin on second messenger generation. When expressed in cos-1 or HEK-293 cells, pleckstrin inhibited 1) the G alpha-mediated activation of phospholipase C beta initiated by thrombin, M1-muscarinic acetylcholine, and angiotensin II receptors, 2) the stimulation of phospholipase C beta by constitutively active Gq alpha, 3) the G beta gamma-mediated activation of phospholipase C beta caused by alpha 2A-adrenergic receptors, and 4) the tyrosine phosphorylation-mediated activation of phospholipase C gamma caused by Trk A. However, pleckstrin had no effect on either the stimulation or inhibition of adenylyl cyclase. The inhibition of phosphoinositide hydrolysis caused by pleckstrin was similar in magnitude to that caused by activating protein kinase C with phorbol 12-myristate 13-acetate (PMA). When combined, pleckstrin and PMA had an additive effect, inhibiting phosphoinositide hydrolysis by as much as 90%. Structure-function analysis highlighted the role of pleckstrin's N-terminal PH domain in these events. Although deleting the C-terminal PH domain had no effect, deleting the N-terminal PH domain abolished activity (but not expression) and mutating a highly conserved tryptophan residue within the N-terminal PH domain decreased activity by one-third. Notably, however, a pleckstrin variant in which the N-terminal PH domain was replaced with a second copy of the C-terminal PH domain was nearly as active as native pleckstrin. These results show that: 1) pleckstrin can inhibit pathways leading to both phospholipase C beta- and phospholipase C gamma-mediated phosphoinositide hydrolysis, 2) this inhibition affects activation of phospholipase C beta mediated by either G alpha or G beta gamma, but does not affect the regulation of adenylyl cyclase activity by G alpha or G beta gamma, 3) although pleckstrin is a substrate for protein kinase C, the effects of pleckstrin and PMA are at least partially independent, 4) the inhibition caused by pleckstrin appears to be mediated by the PH domain at the N terminus, rather than the C terminus of the molecule, and 5) location of the two PH domains within the molecule clearly contributes to their individual activity.2+1
普列克底物蛋白是一种存在于血小板和白细胞中的40 kDa蛋白,它含有两个PH结构域,中间由150个氨基酸的间隔序列隔开。普列克底物蛋白是蛋白激酶C的主要底物,但其功能尚不清楚。本研究检测了普列克底物蛋白对第二信使生成的影响。当在cos-1或HEK-293细胞中表达时,普列克底物蛋白可抑制:1)由凝血酶、M1型毒蕈碱型乙酰胆碱和血管紧张素II受体引发的Gα介导的磷脂酶Cβ激活;2)组成型活性Gqα对磷脂酶Cβ的刺激;3)α2A肾上腺素能受体引起的Gβγ介导的磷脂酶Cβ激活;4)Trk A引起的酪氨酸磷酸化介导的磷脂酶Cγ激活。然而,普列克底物蛋白对腺苷酸环化酶的刺激或抑制均无影响。普列克底物蛋白对磷酸肌醇水解的抑制程度与用佛波醇12-肉豆蔻酸酯13-乙酸酯(PMA)激活蛋白激酶C所引起的抑制程度相似。当联合使用时,普列克底物蛋白和PMA具有相加作用,可将磷酸肌醇水解抑制多达90%。结构-功能分析突出了普列克底物蛋白N端PH结构域在这些事件中的作用。虽然删除C端PH结构域没有影响,但删除N端PH结构域会消除活性(但不影响表达),并且使N端PH结构域内一个高度保守的色氨酸残基发生突变会使活性降低三分之一。然而,值得注意的是,一种将N端PH结构域替换为C端PH结构域的第二个拷贝的普列克底物蛋白变体的活性几乎与天然普列克底物蛋白相同。这些结果表明:1)普列克底物蛋白可抑制导致磷脂酶Cβ和磷脂酶Cγ介导的磷酸肌醇水解的途径;2)这种抑制影响由Gα或Gβγ介导的磷脂酶Cβ激活,但不影响Gα或Gβγ对腺苷酸环化酶活性的调节;3)虽然普列克底物蛋白是蛋白激酶C的底物,但普列克底物蛋白和PMA的作用至少部分是独立的;4)普列克底物蛋白引起的抑制似乎是由分子N端而非C端的PH结构域介导的;5)分子内两个PH结构域的位置显然对它们各自的活性有贡献。